Status:
NOT_YET_RECRUITING
Outcomes of Gillian Barrie Syn
Lead Sponsor:
Assiut University
Conditions:
Outcome of Gillian Barrie
Eligibility:
All Genders
1-18 years
Phase:
NA
Brief Summary
This study analyze clinical and biological factors influencing disease course and outcome. Some research identified factors like disease severity, sensory symptoms, and autonomic instability as indica...
Detailed Description
Guillain-Barré Syndrome (GBS) is the most common cause of acute flaccid paralysis in children worldwide, often presenting with progressive weakness, areflexia, and varying degrees of autonomic and cra...
Eligibility Criteria
Inclusion
- All Pediatric patients (1 month to 18 years old) admitted with acute flaccid ascending paralysis and diagnosed as GBS.
- Consent obtained from parents or legal guardians for participation and follow-up.
Exclusion
- Children with pre-existing neuromuscular disorders. Patients with incomplete medical records or those lost to follow-up. Cases diagnosed as chronic inflammatory demyelinating polyneuropathy (CIDP).
Key Trial Info
Start Date :
October 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT07208370
Start Date
October 1 2025
End Date
December 1 2026
Last Update
October 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assuit University Hospital
Asyut, Egypt